QbDVision: Funding, Investors & Team (Sep 2026)
With QbDVision, users have the ability to handle all aspects of their evolution, risk assessment, and data analysis through a unified login system. This eliminates the inefficiencies and data inconsistencies often seen in older, separate software systems that hinder the sharing of information. As your product and processes expand, QbDVision also grows to provide a better understanding and management. By using our platform, users maintain a complete, historical view of the entire life cycle, enabling them to make informed decisions in a timely manner.
QbDVision has raised $13.0M across 1 funding round on record, the most recent a Series A of $13.0M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
QbDVision Company Profile and Key Stats
Latest funding round on record: May 2025.
QbDVision Funding Rounds
QbDVision Founders and Leadership Team
No contact details are on record for this team yet.
QbDVision Funding Compared to Other Biotechnology Startups
QbDVision's latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like QbDVision in Biotechnology and Austin
Companies Similar to QbDVision
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
QbDVision Funding FAQs
What does QbDVision do?
With QbDVision, users have the ability to handle all aspects of their evolution, risk assessment, and data analysis through a unified login system. This eliminates the inefficiencies and data inconsistencies often seen in older, separate software systems that hinder the sharing of information. As your product and processes expand, QbDVision also grows to provide a better understanding and management. By using our platform, users maintain a complete, historical view of the entire life cycle, enabling them to make informed decisions in a timely manner.
How much funding has QbDVision raised?
QbDVision has raised $13.0M across 1 round on record. The most recent is a Series A of $13.0M announced in May 2025.
When did QbDVision last raise funding?
QbDVision's most recent funding round on record is a Series A of $13.0M, announced in May 2025.
Who founded QbDVision?
FundedIQ lists Ryan Shillington (Founder) at QbDVision.
Where is QbDVision headquartered?
QbDVision is based in Austin, Texas, United States.
How many employees does QbDVision have?
QbDVision is in the 11-50 employee band.
How does QbDVision's funding compare to other Biotechnology startups?
QbDVision's latest round of $13.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's QbDVision Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QbDVision is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.